MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
86.47
+2.36
+2.80%
Opening 15:57 05/14 EDT
OPEN
83.80
PREV CLOSE
84.11
HIGH
86.57
LOW
83.64
VOLUME
2.59M
TURNOVER
--
52 WEEK HIGH
132.26
52 WEEK LOW
57.52
MARKET CAP
33.90B
P/E (TTM)
66.30
1D
5D
1M
3M
1Y
5Y
1D
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
NASDAQ · 1d ago
Dexcom Promotes Jacob S. Leach to President and COO
TipRanks · 1d ago
DexCom Names Operating Chief Leach to Added President Post
Dow Jones · 1d ago
DexCom Promotes COO Jacob Leach To Additional Role Of President
NASDAQ · 1d ago
*DexCom Names Jake Leach to Pres, in Addition to His Role as Oper Chief >DXCM
Dow Jones · 1d ago
DEXCOM ANNOUNCES PROMOTION OF JAKE LEACH TO THE EXPANDED ROLE OF PRESIDENT AND COO
Reuters · 1d ago
*Dexcom Announces Promotion Of Jake Leach To The Expanded Role Of President And COO >DXCM
Dow Jones · 1d ago
QIAGEN Stock Gains Following the Acquisition of Genoox
NASDAQ · 1d ago
More
About DXCM
More
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Recently
Symbol
Price
%Change

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.